Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)

Natalie F Brueckl; Ralph M Wirtz; Fabian P M Reich; Elke Veltrup; Gloria Zeitler; Christian Meyer; Dieter Wuerflein; Joachim H. Ficker; Sebastian Eidt; Wolfgang M Brueckl

doi:10.21037/tlcr-21-587

Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)

Natalie F Brueckl, Ralph M Wirtz, Fabian P M Reich, Elke Veltrup, Gloria Zeitler, Christian Meyer (Co-author), Dieter Wuerflein, Joachim H. Ficker (Co-author), Sebastian Eidt, Wolfgang M Brueckl^* (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article (Journal) › peer-review

5 Citations (Web of Science)

Original language	English
Pages (from-to)	4106-+
Journal	TRANSLATIONAL LUNG CANCER RESEARCH
Volume	10
Issue number	11
DOIs	https://doi.org/10.21037/tlcr-21-587
Publication status	Published - 2021

Keywords

TO-LYMPHOCYTE RATIO
OPEN-LABEL
PERIPHERAL-BLOOD
PD-1 BLOCKADE
DOCETAXEL
NIVOLUMAB
ATEZOLIZUMAB
CHEMOTHERAPY
MULTICENTER
PHASE-3

Access to Document

10.21037/tlcr-21-587

Cite this

Brueckl, N. F., Wirtz, R. M., Reich, F. P. M., Veltrup, E., Zeitler, G., Meyer, C., Wuerflein, D., Ficker, J. H., Eidt, S., & Brueckl, W. M. (2021). Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC). TRANSLATIONAL LUNG CANCER RESEARCH, 10(11), 4106-+. https://doi.org/10.21037/tlcr-21-587

@article{952d82f0a2ed45ce8f2575084d59b074,

title = "Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)",

keywords = "TO-LYMPHOCYTE RATIO, OPEN-LABEL, PERIPHERAL-BLOOD, PD-1 BLOCKADE, DOCETAXEL, NIVOLUMAB, ATEZOLIZUMAB, CHEMOTHERAPY, MULTICENTER, PHASE-3",

author = "Brueckl, {Natalie F} and Wirtz, {Ralph M} and Reich, {Fabian P M} and Elke Veltrup and Gloria Zeitler and Christian Meyer and Dieter Wuerflein and Ficker, {Joachim H.} and Sebastian Eidt and Brueckl, {Wolfgang M}",

note = "Reich; Zeitler; Meyer; Wuerflein; Ficker; Brueckl: Paracelsus Med Univ Nuremberg, Nurnberg, Germany; Reich; Wuerflein; Ficker; Brueckl: Nuernberg Gen Hosp, Nuernberg Lung Canc Ctr, Dept Resp Med Allergol *** Sleep Med, Nurnberg, Germany; Meyer: Nuremberg Gen Hosp, Dept Pathol, Nurnberg, Germany",

year = "2021",

doi = "10.21037/tlcr-21-587",

language = "English",

volume = "10",

pages = "4106--+",

journal = "TRANSLATIONAL LUNG CANCER RESEARCH",

issn = "2218-6751",

publisher = "AME PUBLISHING COMPANY",

number = "11",

}

Brueckl, NF, Wirtz, RM, Reich, FPM, Veltrup, E, Zeitler, G, Meyer, C, Wuerflein, D, Ficker, JH, Eidt, S & Brueckl, WM 2021, 'Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)', TRANSLATIONAL LUNG CANCER RESEARCH, vol. 10, no. 11, pp. 4106-+. https://doi.org/10.21037/tlcr-21-587

Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC). / Brueckl, Natalie F; Wirtz, Ralph M; Reich, Fabian P M et al.
In: TRANSLATIONAL LUNG CANCER RESEARCH, Vol. 10, No. 11, 2021, p. 4106-+.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Predictive value of mRNA expression and dynamic changes from immune related biomarkers in liquid biopsies before and after start of pembrolizumab in stage IV non-small cell lung cancer (NSCLC)

AU - Brueckl, Natalie F

AU - Wirtz, Ralph M

AU - Reich, Fabian P M

AU - Veltrup, Elke

AU - Zeitler, Gloria

AU - Meyer, Christian

AU - Wuerflein, Dieter

AU - Ficker, Joachim H.

AU - Eidt, Sebastian

AU - Brueckl, Wolfgang M

N1 - Reich; Zeitler; Meyer; Wuerflein; Ficker; Brueckl: Paracelsus Med Univ Nuremberg, Nurnberg, Germany; Reich; Wuerflein; Ficker; Brueckl: Nuernberg Gen Hosp, Nuernberg Lung Canc Ctr, Dept Resp Med Allergol *** Sleep Med, Nurnberg, Germany; Meyer: Nuremberg Gen Hosp, Dept Pathol, Nurnberg, Germany

PY - 2021

Y1 - 2021

KW - TO-LYMPHOCYTE RATIO

KW - OPEN-LABEL

KW - PERIPHERAL-BLOOD

KW - PD-1 BLOCKADE

KW - DOCETAXEL

KW - NIVOLUMAB

KW - ATEZOLIZUMAB

KW - CHEMOTHERAPY

KW - MULTICENTER

KW - PHASE-3

U2 - 10.21037/tlcr-21-587

DO - 10.21037/tlcr-21-587

M3 - Original Article (Journal)

C2 - 35004242

SN - 2218-6751

VL - 10

SP - 4106-+

JO - TRANSLATIONAL LUNG CANCER RESEARCH

JF - TRANSLATIONAL LUNG CANCER RESEARCH

IS - 11

ER -